"Let our investigators test your new pharmaceutical products in our research center. For more details, contact Providence Clinical Research in North Hollywood, CA."

During the past decade, Velocity Clinical Research, North Hollywood conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Velocity Clinical Research, North Hollywood" #1 sponsor was "Pfizer" with 5 trials, followed by "BioNTech SE" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored and "Janssen Vaccines & Prevention B.V." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Velocity Clinical Research, North Hollywood" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Velocity Clinical Research, North Hollywood" are "COVID-19" (2 trials), "Episodic Migraine" (2 trials), "Migraine" (2 trials), "SARS-CoV-2 Infection" (2 trials) and "Acute Treatment of Migraine" (1 trials). Many other conditions were trialed in "Velocity Clinical Research, North Hollywood" in a lesser frequency.

Most popular intervention types in "Velocity Clinical Research, North Hollywood" are "Drug" (8 trials), "Biological" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "BNT162b2" (2 trials), "Rimegepant" (2 trials), "ACP-044 Dose A" (1 trials) and "ACP-044 Dose B" (1 trials). Other intervention names were less common.

The vast majority of trials in "Velocity Clinical Research, North Hollywood" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Velocity Clinical Research, North Hollywood". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Velocity Clinical Research, North Hollywood, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Velocity Clinical Research, North Hollywood, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".